Callan Family Office’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
48,274
-3,208
-6% -$925K 0.27% 73
2026
Q1
$16.2M Sell
51,482
-5,082
-9% -$1.77M 0.37% 49
2025
Q4
$19.1M Buy
56,564
+7,908
+16% +$2.7M 0.41% 44
2025
Q3
$15.2M Sell
48,656
-413
-0.8% -$122K 0.48% 38
2025
Q2
$14.7M Buy
49,069
+19,487
+66% +$5.61M 0.46% 40
2025
Q1
$8.23M Buy
29,582
+17,512
+145% +$4.4M 0.62% 28
2024
Q4
$2.71M Buy
12,070
+10,352
+603% +$2.43M 0.17% 116
2024
Q3
$387K Buy
1,718
+433
+34% +$101K 0.07% 120
2024
Q2
$290K Buy
+1,285
New +$298K 0.06% 124
2023
Q3
Sell
-1,079
Closed -$208K 95
2023
Q2
$208K Buy
+1,079
New +$187K 0.05% 105

Other funds holding COR

Callan Family Office's COR Position: Q2 2026 in Review

Callan Family Office reduced its Cencora (COR) stake by 6.2% in Q2 2026, selling an estimated $925K and leaving 48,274 shares worth $13.7M. The position accounts for 0.27% of the portfolio, ranked #73.

Callan Family Office first reported a position in COR in Q2 2023 and has held it in 10 quarters since. The position peaked at $19.1M in Q4 2025. 1,343 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • Callan Family Office held 48,274 shares of Cencora worth $13.7M as of Q2 2026.
  • Callan Family Office sold 3,208 Cencora shares in Q2 2026, an estimated $925K.
  • Cencora made up 0.27% of Callan Family Office's portfolio in Q2 2026, its #73 holding.
  • Callan Family Office first reported a position in Cencora in Q2 2023 and has held it in 10 quarters since.
  • Callan Family Office's Cencora position peaked at $19.1M in Q4 2025.
  • 1,343 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.